Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function

被引：0
|
作者：
Hillary G. Caruso
Ryuma Tanaka
Jiyong Liang
Xiaoyang Ling
Aria Sabbagh
Verlene K. Henry
Tiara L. Collier
Amy B. Heimberger
机构：
[1] The University of Texas MD Anderson Cancer Center,Division of Pediatrics
[2] The University of Texas MD Anderson Cancer Center,Department of Neurosurgery
来源：
Journal of Neuro-Oncology | 2019年 / 145卷
关键词：
Chimeric antigen receptor T cell; Exhaustion markers; PD-1; PD-L1; LAG-3; TIM-3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 439
页数：10
相关论文
共 25 条
  • [21] CO-STIMULATION VIA PD1-41BB CHIMERIC SWITCH RECEPTOR ENHANCES FUNCTION OF TCR-T CELLS IN AN IMMUNE-SUPPRESSIVE MILIEU AND UNDER CHRONIC ANTIGEN STIMULATION
    Salvermoser, Melanie
    Gerget, Maria
    Hasselmann, Franziska
    Noessner, Elfriede
    Ellinger, Christian
    Braun, Monika
    Schendel, Dolores
    Sommermeyer, Daniel
    Sailer, Nadja
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A369 - A369
  • [22] Direct Comparison of In Vivo Fate of Second and Third-Generation CD19-Specific Chimeric Antigen Receptor (CAR)-T Cells in Patients with B-Cell Lymphoma: Reversal of Toxicity from Tonic Signaling
    da Silva, Diogo Gomes
    Mukherjee, Malini
    Srinivasan, Madhuwanti
    Dakhova, Olga
    Liu, Hao
    Grilley, Bambi
    Gee, Adrian P.
    Neelapu, Sattva S.
    Rooney, Cliona M.
    Heslop, Helen E.
    Savoldo, Barbara
    Dotti, Gianpietro
    Brenner, Malcolm K.
    Mamonkin, Maksim
    Ramos, Carlos A.
    BLOOD, 2016, 128 (22)
  • [23] Abrogation of Immune Effector Cell Neurotoxicity Syndrome (ICANS) By Rimiducid (RIM) in Patients Treated with CD19-Specific Chimeric Antigen Receptor Modified T-Cells (CAR-T) Engineered with an Inducible Caspase 9 (iC9 CAR.19)-Clinical and Pharmacodynamic Correlates
    Foster, Matthew C.
    Savoldo, Barbara
    Lau, Winnie
    Rubinos, Clio
    Grover, Natalie S.
    Armistead, Paul M.
    Coghill, James M., Jr.
    Jamieson, Katarzyna Joanna
    Hagan, Robert
    Morrison, J. Kaitlin
    Buchanan, Faith Brianne
    Cheng, Catherine Joyce Arago
    Ivanova, Anastasia
    Cavallo, Tammy
    West, John
    Gonzalez, Megan
    Serody, Jonathan S.
    Dotti, Gianpietro
    BLOOD, 2022, 140 : 7437 - 7438
  • [24] DIRECT COMPARISON OF IN VIVO FATE OF SECOND AND THIRD-GENERATION CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS IN PATIENTS WITH B CELL NON-HODGKIN LYMPHOMA (B-NHL): REVERSAL OF TOXICITY FROM TONIC SIGNALING
    da Silva, D. Gomes
    Mukherjee, M.
    Madhuwanti, S.
    Dakhova, O.
    Liu, H.
    Grilley, B.
    Gee, A.
    Neelapu, S. S.
    Rooney, C.
    Heslop, H.
    Savoldo, B.
    Dotti, G.
    Brenner, M.
    Mamonkin, M.
    Ramos, C. A.
    CYTOTHERAPY, 2017, 19 (05) : S9 - S9
  • [25] Direct Comparison of in Vivo Fate of Second and Third-Generation CD19-Specific Chimeric Antigen Receptor (CAR)-T Cells in Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL): Reversal of Toxicity From Tonic Signaling
    da Silva, Diogo Gomes
    Mukherjee, Malini
    Madhuwanti, Srinivasan
    Dakhova, Olga
    Liu, Hao
    Grilley, Bambi
    Gee, Adrian P.
    Neelapu, Sattva S.
    Rooney, Cliona M.
    Heslop, Helen E.
    Savoldo, Barbara
    Dotti, Gianpietro
    Brenner, Malcolm K.
    Mamonkin, Maksim
    Ramos, Carlos A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S40 - S41
123